ConductScience.org, home

Paper4136142

Errors in DNA replication as a basis of malignant changes.

Loeb LA and 2 others. Cancer Res, 1974. Cited by 402 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Errors in DNA replication as a basis of malignant changes. Papers, record 4136142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4136142

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Errors in DNA replication as a basis of malignant changes.
PubMed
Journal
Cancer Res
PubMed
Year
1974
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
402
iCite
Relative citation ratio, by iCite
6.25
iCite
Revised in PubMed
2015-11-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Loeb LAL A
2Springgate CFC F
3Battula NN

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA NucleotidyltransferasesMajor topic
DNA ReplicationMajor topic
NeoplasmsMajor topic
Animals
Avian Leukosis Virus
Base Sequence
DNA, Neoplasm
Genotype
Humans
Leukemia
Mutation
Nucleotides
Polynucleotides
RNA-Directed DNA Polymerase
Templates, Genetic

Source PubMed

Cited by188

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 402 citations.

PMIDTitleJournalYearIn PapersSource
42,738,257Selective Inhibition of DNA Polymerase Proofreading: A Metabolic-Fidelity Mechanism Explains Agent Orange-Associated Myelodysplasia.Cancers (Basel)2026https://conductscience.org/library/papers/42738257PubMed
42,707,399Motif-centered analyses reveal universal and tissue-specific mutagenic mechanisms operating in the human body.NAR Cancer2026https://conductscience.org/library/papers/42707399PubMed
42,042,006Selective Inhibition of Proofreading Exonucleases: The Central Role in Obesity-Associated Carcinogenesis.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42042006PubMed
42,015,304Radiogenomic landscape of the hallmarks of cancer.Biomark Res2026https://conductscience.org/library/papers/42015304PubMed
41,814,545Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure.Stem Cells Transl Med2026https://conductscience.org/library/papers/41814545PubMed
41,756,945Motif-Centered Analyses Reveal Universal and Tissue-Specific Mutagenic Mechanisms Operating in the Human Body.bioRxiv2026https://conductscience.org/library/papers/41756945PubMed
40,610,469Personalized cancer treatment strategies incorporating irreversible and reversible drug resistance mechanisms.NPJ Syst Biol Appl2025https://conductscience.org/library/papers/40610469PubMed
39,273,111The Spiral Model of Evolution: Stable Life Forms of Organisms and Unstable Life Forms of Cancers.Int J Mol Sci2024https://conductscience.org/library/papers/39273111PubMed
38,231,464Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?Clin Exp Med2024https://conductscience.org/library/papers/38231464PubMed
38,100,001Signification and Application of Mutator and Antimutator Phenotype-Induced Genetic Variations in Evolutionary Adaptation and Cancer Therapeutics.J Microbiol2023https://conductscience.org/library/papers/38100001PubMed
37,854,902DNA mutilation: A telltale sign of cancer inception.J Oral Maxillofac Pathol2023https://conductscience.org/library/papers/37854902PubMed
37,239,369Examining Sporadic Cancer Mutations Uncovers a Set of Genes Involved in Mitochondrial Maintenance.Genes (Basel)2023https://conductscience.org/library/papers/37239369PubMed
37,122,741Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities.Front Immunol2023https://conductscience.org/library/papers/37122741PubMed
36,781,990Survival improvement for patients with metastatic colorectal cancer over twenty years.NPJ Precis Oncol2023https://conductscience.org/library/papers/36781990PubMed
36,168,102Cancer as an infective disease: the role of EVs in tumorigenesis.Mol Oncol2023https://conductscience.org/library/papers/36168102PubMed
35,850,061Extrinsic proofreading.DNA Repair (Amst)2022https://conductscience.org/library/papers/35850061PubMed
35,326,618Polymerase Epsilon-Associated Ultramutagenesis in Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/35326618PubMed
35,216,513The Role of Natural Polymorphic Variants of DNA Polymerase β in DNA Repair.Int J Mol Sci2022https://conductscience.org/library/papers/35216513PubMed
35,052,441Genome Chaos, Information Creation, and Cancer Emergence: Searching for New Frameworks on the 50th Anniversary of the "War on Cancer".Genes (Basel)2021https://conductscience.org/library/papers/35052441PubMed
34,944,853Therapeutic Targets of KRAS in Colorectal Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34944853PubMed

See all 188 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4136142

GET https://conductscience.org/api/papers/v1/4136142/cited_by?page=2